Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review

Diseases

CarloEnrico Traverso¹  Aldo Vagge¹  Giuseppe Giannaccare²  Lorenzo Ferro Desideri³  Andrea Lembo⁴  Paolo Nucci⁴  Massimiliano Serafino⁴ 

[1] Eye Clinic of Genoa, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genova, 16132 Genova, Italy;Ophthalmology Unit, Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, S. Orsola-Malpighi Teaching Hospital, 40138 Bologna, Italy;School of Medicine and Pharmacy, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132 Genoa, Italy;University Eye Clinic San Giuseppe Hospital, University of Milan, 20162 Milano, Italy;

关键词: congenital nasolacrimal duct obstruction;    lacrimal apparatus;    tears;   

DOI  :  10.3390/diseases6040096

来源: DOAJ

【 摘 要 】

Congenital nasolacrimal duct obstruction (CNLDO) is a common condition causing excessive tearing or mucoid discharge from the eyes, due to blockage of the nasolacrimal duct system. Nasolacrimal duct obstruction affects as many as 20% children aged <1 year worldwide and is often resolved without surgery. Available treatment options are conservative therapy, including observation, lacrimal sac massage and antibiotics, and invasive therapy. Observation, combined with conservative options, seems to be the best option in infants aged <1 year. Meanwhile, in children aged >1 year, nasolacrimal probing successfully addresses most obstructions. However, the most favorable timing for probing remains controversial. To alleviate persistent epiphora and mucous drainage that is refractory to probing, repeat probing, silicone tube intubation, balloon catheter dilation or dacryocystorhinostomy can be considered as available treatment options. Our review aims to provide an update to CNDO management protocols.

【 授权许可】

Unknown